FBLN5 and neoplasm: As shown in Table 1, patients with an advanced tumor stage, a higher rate of distant metastasis, and TNM stages III-IV had significantly higher fibulin-5 expression than did patients with stage I-II tumors (p<0.001), no distant metastasis (p=0.042), and TNM stages I/II (p<0.001).